Skip to main content
. 2017 Jun 1;8(46):81295–81304. doi: 10.18632/oncotarget.18333

Table 4. Comparison of genotype distribution frequencies of the allele and genotypes of polymorphic loci in the IS and control groups.

SNPs Stroke (298 cases) Control (303 cases) AOR (95% CI) P value
miR-149T>C
TT 131 (44.0) 121 (39.9) 1.000 (reference)
CT 127 (42.6) 136 (44.9) 1.108 (0.879–1.647) 0.756
CC 40 (13.4) 46 (15.2) 1.226(0.963–1.726) 0.301
Dominant model (TT vs CT + CC) 0.958(0.713–1.295) 0.363
Recessive model(TT + CT vs CC) 0.776(0.659–1.375) 0.575
T 389 (65.3) 378 (62.4) 1.000 (reference)
C 207 (34.7) 228 (37.6) 1.156 (0.916–1.597) 0.325
HWE P 0.300 0.447
miR-499A>G
AA 215 (72.1) 244 (80.5) 1.000 (reference)
AG 78 (26.2) 53 (17.5) 1.339 (1.126–1.967) 0.037
GG 5 (1.7) 6 (2.0) 1.077 (0.361–2.024) 0.669
Dominant model (AAvs AG + GG) 1.621 (1.079–2.516) 0.027
Recessive model (AA+ AG vs GG) 0.879 (0.531–2.557) 0.665
A 508 (85.2) 541 (89.3) 1.000 (reference)
G 88 (14.8) 65 (10.7) 1.455 (1.019–2.381) 0.039
HWE P 0.491 0.131
miR-146aC>G
CC 129 (43.3) 119 (39.3) 1.000 (reference)
CG 130 (43.6) 139 (45.9) 1.163(0.939–1.681) 0.596
GG 39 (13.1) 45 (14.9) 0.991(0.533–1.475) 0.557
Dominant model (CC vs CG + GG) 1.015 (0.623–1.273) 0.329
Recessive model (CC + CG vs GG) 1.006(0.543–1.319) 0.317
C 388 (65.1) 377 (62.2) 1.000(reference)
G 208 (34.9) 229 (37.8) 1.091 (0.075–1.451) 0.776
HWE P 0.490 0.672
miR-196a2T>C
TT 73 (24.5) 75 (24.8) 1.000 (reference)
CT 138 (46.3) 159 (52.5) 1.257 (0.976–2.058) 0.190
CC 87 (29.2) 69 (22.8) 1.339 (0.894–1.996) 0.216
Dominant model (TTvsCT + CC) 0.803 (0.576–1.127) 0.249
Recessive model (CCvsCT +TT) 1.376 (0.759–1.963) 0.173
T 284 (47.7) 309 (51.0) 1.000 (reference)
C 312 (52.3) 297 (49.0) 1.035 (0.799–1.541) 0.559
HWE P 0.215 0.385

Note: HWE P: Wendy–Harberger's law; miRNA: microRNA; 95% CI: 95% confidence interval; AOR: adjusted OR value.

Corrected factors of the AOR include gender, age, smoking, hypertension, diabetes, high Hcy, and high Lp(a).